RPG Life Sciences fails to get EU GMP certification

K.S. Badri Narayanan Chennai | Updated on January 11, 2012 Published on January 11, 2012

The stock of RPG Life Sciences remained firm at Rs 69, up 0.3 per cent, despite the company having failed to get a nod from the German Government.

The company informed the BSE that the Ministry of Social and Family Affairs, Health and Consumer Protection, Hamburg, Germany did not grant EU GMP for the company's API facility at Navi Mumbai, Maharashtra, post their inspection citing certain deficiencies.

The company said that this move will have adverse impact on its export business. "The company has taken immediate remedial measures, and is reviewing all the issues raised by the said health authority and is working towards resolving them in a time-bound manner," RPG Life Sciences said in a statement to the exchange.

The company continues to hold a valid WHO GMP and TGA, Australia certification for its facilities, the statement added.

Published on January 11, 2012
This article is closed for comments.
Please Email the Editor